BUYINS.NET: BSMD, CYBE, CRFN, FCCO, LMAT, ANLY Expected To Be Lower After Earnings Releases on Wednesday

Jul 24, 2009 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, July 29th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and July earnings reports. BioSphere Medical (NASDAQ: BSMD), CyberOptics (NASDAQ: CYBE), Crescent Financial (NASDAQ: CRFN), First Community Corp (NASDAQ: FCCO), LeMaitre Vascular (NASDAQ: LMAT) and Analysts International Corp (NASDAQ: ANLY) are all expected to be lower after their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php- The following stocks are expected to go lower after earnings are released Wednesday: Symbol Company # of Reports Quarter Release Time BSMD BioSphere Medical 12 quarters Q2 After CYBE CyberOptics Corporation 12 quarters Q2 After CRFN Crescent Financial 12 quarters Q2 During FCCO First Community Corp. 12 quarters Q2 During LMAT LeMaitre Vascular, Inc. 12 quarters Q2 After ANLY Analysts International July earnings Q2 Before Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

BioSphere Medical, Inc. (NASDASQ: BSMD) develops, manufactures, and markets products for medical procedures that use embolotherapy. The company focuses on the treatment of symptomatic uterine fibroids, which are noncancerous, or benign, hypervascular tumors growing within or on the wall of the uterus, using a procedure called uterine fibroid embolization. Its microsphere products include Embosphere Microspheres for the treatment of uterine fibroids, hypervascularized tumors, and other arteriovenous malformations; EmboGold Microspheres for Hypervascularized tumors (other than uterine fibroids) and arteriovenous malformations; HepaSphere Microspheres to treat primary and metastatic liver cancer; and QuadraSphere Microspheres for the treatment of Hypervascularized tumors and arteriovenous malformations. The companyas delivery system products include EmboCath Plus Infusion Microcatheter for the infusion of various diagnostic, embolic, and therapeutic agents and super-selective angiography within peripheral vasculature; Sequitor Steerable Guidewire for diagnostic and interventional procedures within peripheral vasculature; and Segway Guidewire for peripheral embolization procedures. In addition, it develops MR Microspheres and Resorbable Microspheres, which are in preclinical research stages to treat uterine fibroids, hypervascularized tumors, and other arteriovenous malformations. The company also sells barium delivery kits and other ancillary products in the European Union for use in gastrointestinal medical testing. BioSphere Medical, Inc. markets its embolotherapy and delivery systems products through direct sales force in the United States and France, as well as through distributors primarily in Europe, Asia, Canada, the Middle East, Africa, and South America. The company was founded in 1993 and is based in Rockland, Massachusetts.

CyberOptics Corporation (NASDAQ: CYBE) supplies optical process control sensors and inspection systems that are used to control the manufacturing process, and to ensure the quality of electronic circuit boards manufactured by its customers using surface mount technology (SMT) in the United States. The company operates in two segments, Electronic Assembly and Semiconductor. The Electronic Assembly segment engages in the design, manufacture, and sale of optical process control sensors and inspection systems for the electronics assembly equipment market. Its SMT systems product line consists of stand-alone measurement and inspection systems used in the SMT electronic assembly industry for process control and inspection. The Semiconductor segment engages in the design, manufacture, and sale of optical and other process control sensors and related equipment for the semiconductor capital equipment market. It also engages in the manufacture and sale of sensors that assist with yield improvement, and the placement and transport of wafers during semiconductor fabrication. This segmentas product portfolio comprises waferSense sensors, wafer mapping and alignment sensors, and frame grabber products and machine vision subsystems. The company sells its product to manufacturers of electronic circuit board assembly equipment, manufacturers of semiconductor DRAM memory, semiconductor capital equipment manufacturers, and end-user electronic assembly manufacturers. CyberOptics Corporation markets its products through direct sales, independent representatives, and distributors. The company was founded in 1984 and is headquartered in Minneapolis, Minnesota.

Crescent Financial Corporation (NASDAQ: CRFN) operates as the bank holding company for Crescent State Bank that provides commercial and retail banking products and services to individuals and small-to-medium sized businesses. The company offers a range of deposit products, including non-interest bearing checking accounts, interest bearing checking and savings accounts, money market accounts, and certificates of deposit. Its loan portfolio comprises commercial and personal loans; mortgage services; real estate mortgage and construction loans; small business administration guaranteed loans; and consumer loans, including automobile loans, boat and recreational vehicle financing, home equity and home improvement loans, various secured and unsecured personal loans, and residential real estate loans. The company also offers credit cards, investment, online banking, bill payment, and wire transfer services. As of March 31, 2009, it operated 14 banking offices in Cary, Apex, Clayton, Holly Springs, Southern Pines, Pinehurst, Sanford, Garner, Raleigh, Wilmington, and Knightdale, North Carolina; and a loan production office in Raleigh, North Carolina. The company was founded in 1998 and is headquartered in Cary, North Carolina.

First Community Corporation (NASDAQ: FCCO) operates as the bank holding company for First Community Bank, N.A., which provides banking products and services for small-to-medium sized businesses, professional concerns, and individuals primarily in Richland, Lexington, Kershaw, and Newberry counties of South Carolina. It accepts various deposit products, such as checking accounts, negotiable order of withdrawal accounts, savings accounts, individual retirement accounts, money market accounts, certificates of deposits, and other time deposits. The company also provides commercial loans, which include secured and unsecured loans for working capital, business expansion, and purchase of equipment and machinery; consumer loans, including secured and unsecured loans for financing automobiles, home improvements, education, and personal investments; and real estate construction and acquisition loans. In addition, it offers Internet banking, cash management services, safe deposit boxes, travelers checks, direct deposit of payroll, social security checks, and automatic drafts for various accounts; non-deposit investment products and other investment brokerage services; and credit card services. The company primarily serves professionals and small-to medium-sized businesses, including consumer and commercial, mortgage, brokerage and investment, and insurance services. As of December 31, 2007, it operated its main office in Lexington, South Carolina, as well as 11 full-service offices, including 2 offices located in Lexington, and 1 each in Forest Acres, Irmo, Cayce-West Columbia, Gilbert, Chapin, Northeast Columbia, Prosperity, Newberry, and Camden. The company was founded in 1994 and is headquartered in Lexington, South Carolina.

LeMaitre Vascular, Inc. (NASDAQ: LMAT) develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The companyas products include TAArget Thoracic Stent Graft for use in the repair of thoracic aortic aneurysm and dissection; UniFit Abdominal Stent Graft for abdominal aortic aneurysm; aSpire Covered Stent for holding open major leg arteries that have had blockages removed; LeverEdge Contrast Injector for injection of media to monitor blood flow and determine vessel location; VascuTape Radiopaque Tape for the improvement of endovascular procedures; AnastoClip Vessel Closure System for the attachment of blood vessels, primarily for dialysis access; and Albograft Vascular Graft for use in bypass and replacement procedures. Its products also include EndoRE Remote Endarterectomy Devices for removal of blockages in the major arteries of the leg; InvisiGrip Vein Stripper, a Single-incision removal of varicose veins; Expandable LeMaitre Valvulotome for destructing vein valves to create vein bypass graft; Pruitt-Inahara, Pruitt F3, and Flexcel Carotid Shunts for the facilitation of blood flow to brain during carotid plaque removal; LeMaitre Balloon Catheters for the removal of blood clots, occlusion, and facilitation of blood flow; OptiLock Implantable Port, a central venous infusion of drugs and nutrients; and Reddick Cholangiogram Catheter for the introduction of dye into the cystic duct. It sells its products to vascular surgeons and interventionalists through direct sales force and a network of distributors primarily in North America, the European Union, and Japan. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Analysts International Corporation (NASDAQ: ANLY) provides information technology (IT) solutions and services in the United States and Canada. It provides IT staffing and project based services, including application development and integration, systems integration, portals and collaboration solutions, network and infrastructure solutions, and managed services. The company offers temporary, permanent, and supplemental staffing services; application solutions for government include justice integration and business process optimization, government business intelligence, inter-state information sharing, and strategic planning solutions; and Lawson Solutions, a suite of enterprise resource planning enhancement, implementation, and management services to address specific technical, functional, or business requirements of enterprises. It also provides Microsoft solutions; and infrastructure solutions comprising unified communications, data center, wireless, security, and virtualization solutions. Analysts International serves electronics/manufacturing, government/public administration, professional/business services, financial/insurance services, oil and chemical, telecommunications, health care, and merchandising industry groups. The company was founded in 1966 and is headquartered in Minneapolis, Minnesota.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com One example from the SqueezeTrigger database is approximately 2.6 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering! About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each monthas short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Thomas Ronk, CEO, SqueezeTrigger.com Tel: +1 800 715 9999 e-mail: Tom@SqueezeTrigger.com WWW: http://www.SqueezeTrigger.com ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

[ Back To Homepage ]

| More

The World's Largest Communications And Technology Community

Technology Marketing Corporation,
800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800; Fx: 203-866-3326
General comments: tmc@tmcnet.com. Comments about this site: webmaster@tmcnet.com.

» About » Contact » Advertise